Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells (Nature, (2017), 546, 7656, (168-172), 10.1038/nature22359);CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

Nature

Volumn 546, Issue 7656, 2017, Pages 168-172

  Kim, Jiyeon ^a   Hu, Zeping ^a   Cai, Ling ^a   Li, Kailong ^a   Choi, Eunhee ^b   Faubert, Brandon ^a   Bezwada, Divya ^a   Rodriguez Canales, Jaime ^c   Villalobos, Pamela ^c   Lin, Yu Fen ^b   Ni, Min ^a   Huffman, Kenneth E ^a   Girard, Luc ^a   Byers, Lauren A ^c   Unsal Kacmaz, Keziban ^d   Peña, Christopher G ^b,h   Heymach, John V ^c   Wauters, Els ^e   Vansteenkiste, Johan ^e   Castrillon, Diego H ^b   Chen, Benjamin P C ^b   Wistuba, Ignacio ^c   Lambrechts, Diether ^f,g   Xu, Jian ^a   Minna, John D ^a   Deberardinis, Ralph J ^a,b   more..

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d PFIZER INC   (United States)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ARGININOSUCCINATE SYNTHASE; BETA ACTIN; CARBAMOYL PHOSPHATE; CARBAMOYL PHOSPHATE SYNTHASE; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CISPLATIN; CITRULLINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA POLYMERASE; DOXYCYCLINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HISTONE H2AX; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; K RAS PROTEIN; MESSENGER RNA; ORNITHINE; ORNITHINE DECARBOXYLASE; PROTEIN; PROTEIN KINASE LKB1; PYRIMIDINE; RENILLA LUCIFERIN 2 MONOOXYGENASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SODIUM NITRITE; THYMIDINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TEAD4; UNCLASSIFIED DRUG; URIDINE; AMMONIA; BICARBONATE; DNA; DNA DIRECTED DNA POLYMERASE; KRAS PROTEIN, HUMAN; NITROGEN; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; PURINE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; STK11 PROTEIN, HUMAN;

BIOCHEMISTRY; CANCER; CELLS AND CELL COMPONENTS; CHEMICAL COMPOUND; DNA; ENZYME; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH; METABOLISM; MITOCHONDRION; MUTATION; TOXICITY; TUMOR;

ANALYTICAL PARAMETERS; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPLETION; DNA DAMAGE; DNA SYNTHESIS; DRUG EFFICACY; ENHANCER REGION; FEMALE; GENE EXPRESSION; GENE LOSS; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; LUNG CANCER CELL LINE; MALE; METABOLIC BALANCE; METABOLIC REGULATION; METABOLOMICS; MITOCHONDRION; MOUSE; MUTANT; NON SMALL CELL LUNG CANCER; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PYRIMIDINE METABOLISM; PYRIMIDINE TO PURINE RATIO; UREA CYCLE; ANIMAL; BIOSYNTHESIS; CELL DEATH; CELL PROLIFERATION; DEFICIENCY; DNA REPLICATION; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; GENE SILENCING; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY;

AMMONIA; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BICARBONATES; CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA); CARBAMYL PHOSPHATE; CARCINOMA, NON-SMALL-CELL LUNG; CELL DEATH; CELL PROLIFERATION; DNA; DNA DAMAGE; DNA REPLICATION; DNA-DIRECTED DNA POLYMERASE; FEMALE; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MALE; METABOLOMICS; MICE; MITOCHONDRIA; NITROGEN; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS P21(RAS); PURINES; PYRIMIDINES; S PHASE; TRANSCRIPTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85020182527     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-019-1133-3     Document Type: Erratum

References (30)

1. Calles, A. et al. Immunohistochemical loss of LKB1 is a biomarker for more aggressive biology in KRAS-mutant lung adenocarcinoma. Clin. Cancer Res. 21, 2851-2860 (2015).
2. Ji, H. et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 448, 807-810 (2007).
3. Liu, Y. et al. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. Cancer Discov. 3, 870-879 (2013).
4. Kim, H. S. et al. Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer. Cell 155, 552-566 (2013).
5. Liu, H., Dong, H., Robertson, K. & Liu, C. DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate synthetase 1 (CPS1) in human hepatocellular carcinoma. Am. J. Pathol. 178, 652-661 (2011).
6. Rabinovich, S. et al. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature 527, 379-383 (2015).
7. Celiktas, M. et al. Role of CPS1 in cell growth, metabolism, and prognosis in LKB1-inactivated lung adenocarcinoma. J. Natl. Cancer Inst. 109, 1-9 (2016).
8. Shackelford, D. B. & Shaw, R. J. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat. Rev. Cancer 9, 563-575 (2009).
9. Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262 (2012).
10. Mo, J.-S. et al. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat. Cell Biol. 17, 500-510 (2015).
11. Sun, Y. et al. Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway. Onco Targets Ther. 9, 2845-2853 (2016).
12. Kim, H. G. et al. Metformin inhibits P-glycoprotein expression via the NF-? B pathway and CRE transcriptional activity through AMPK activation. Br. J. Pharmacol. 162, 1096-1108 (2011).
13. Chen, K. C., Vannais, D. B., Jones, C., Patterson, D. & Davidson, J. N. Mapping of the gene encoding the multifunctional protein carrying out the first three steps of pyrimidine biosynthesis to human chromosome 2. Hum. Genet. 82, 40-44 (1989).
14. Simmer, J. P. et al. Mammalian dihydroorotase: nucleotide sequence, peptide sequences, and evolution of the dihydroorotase domain of the multifunctional protein CAD. Proc. Natl Acad. Sci. USA 87, 174-178 (1990).
15. Ben-Sahra, I., Howell, J. J., Asara, J. M. & Manning, B. D. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 339, 1323-1328 (2013).
16. Wraith, J. E. Ornithine carbamoyltransferase deficiency. Arch. Dis. Child. 84, 84-88 (2001).
17. Poli, J. et al. dNTP pools determine fork progression and origin usage under replication stress. EMBO J. 31, 883-894 (2012).
18. Anglana, M., Apiou, F., Bensimon, A. & Debatisse, M. Dynamics of DNA replication in mammalian somatic cells: nucleotide pool modulates origin choice and interorigin spacing. Cell 114, 385-394 (2003).
19. Petermann, E., Orta, M. L., Issaeva, N., Schultz, N. & Helleday, T. Hydroxyureastalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol. Cell 37, 492-502 (2010).
20. Labib, K. & Hodgson, B. Replication fork barriers: pausing for a break or stalling for time? EMBO Rep. 8, 346-353 (2007).
21. Reichard, P. Interactions between deoxyribonucleotide and DNA synthesis. Annu. Rev. Biochem. 57, 349-374 (1988).
22. Shackelford, D. B. et al. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell 23, 143-158 (2013).
23. Son, J. et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496, 101-105 (2013).
24. Mullen, A. R. et al. Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects. Cell Rep. 7, 1679-1690 (2014).
25. Yang, C. et al. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res. 69, 7986-7993 (2009).
26. Jackson, D. A. & Pombo, A. Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. J. Cell Biol. 140, 1285-1295 (1998).
27. Huang, J. et al. Dynamic control of enhancer repertoires drives lineage and stage-specific transcription during hematopoiesis. Dev. Cell 36, 9-23 (2016).
28. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281-2308 (2013).
29. Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84-87 (2014).
30. Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543-550 (2014).